What is the glucagon receptor?
The glucagon receptor is a G-protein-coupled receptor that binds glucagon — the pancreatic alpha-cell hormone that opposes insulin’s glucose-lowering action. The third receptor arm of triple agonists like; engagement drives energy-expenditure and lipid-mobilisation effects distinct from the incretin-receptor pharmacology.
What the research literature says
The glucagon receptor is a Class B G-protein-coupled receptor expressed primarily on hepatocytes (where glucagon drives hepatic glucose production via glycogenolysis and gluconeogenesis) and on adipocytes (where it stimulates lipolysis). Native glucagon is a 29-amino-acid peptide secreted by pancreatic alpha cells in response to low blood glucose, serving as the principal counter-regulatory hormone to insulin.
The first triple-receptor incretin/glucagon agonists are studied to reach late-stage clinical development. The Jastreboff phase 2 obesity trial documented substantial weight reduction at higher dose levels (PMID 37366315). The Rosenstock phase 2 type 2 diabetes trial documented glycemic and weight effects (PMID 37385280). The Sanyal MASLD phase 2a trial extended the framework into liver-fat-content endpoints (PMID 38858523).
The hypothesis driving the triple-receptor strategy: glucagon-receptor agonism contributes energy-expenditure and lipid-mobilisation effects that complement the glucose-lowering and weight-reducing effects of GIP + GLP-1 dual agonism. The Doggrell review consolidates the early signals across obesity and type 2 diabetes contexts (PMID 37947489).
Why this matters in research context
The glucagon receptor matters in peptide-research contexts as the third pharmacological arm of an investigational triple agonist and the broader emerging triple-receptor incretin/glucagon agonist class. Researchers studying triple-receptor agonists should anchor protocol design to the triple-receptor framework — the additional glucagon-receptor arm produces pharmacology distinct from the dual-agonist (tirzepatide) and single-agonist (semaglutide) classes.
Related compounds
Related research questions
References
Research-questions pages describe research-context use of peptide-research terminology. They do not constitute medical, veterinary, or clinical advice. Every compound in the Ronin catalog is sold strictly for laboratory and research use only.